Technology

BOSTON MA, UNITED STATES, March 17, 2025 – LarmorBio, a Massachusetts Institute of Technology (MIT) start-up pioneering the use of microscale magnetic resonance (MR) for life sciences research and clinical diagnostics, is announcing the recent expansion of its board of directors and senior executive team with seasoned life science executives. The company makes these changes as it anticipates scaling the business commercially in the second half of 2025.

LarmorBio, a Massachusetts Institute of Technology (MIT) start-up pioneering the use of microscale magnetic resonance (MMR) relaxometry for life sciences research and clinical diagnostics, is announcing several recent peer-reviewed publications. These publications build upon the supporting evidence that MMR can be used to non-invasively assess cellular senescence, viability, and proliferation without the need for dye or antibody labelling, enabling early, near real-time intervention that is impossible with today’s bioprocessing methods. These milestones represent a significant step toward addressing critical unmet needs in scalable cell and gene manufacturing. MMR holds the promise to improve cell potency, reduce contamination risk and improve production yields in an entirely new way.

A new editorial article in the Lancet Journal highlights the emerging clinical need to detect and treat prediabetic patients and the significant need for a rapid, low cost blood test to better identify these patients.

Currently in the United States nearly half of heart attacks and strokes occur in patients that are not deemed high-risk by traditional risk factors such as high blood pressure, high cholesterol, and diabetes…

Inflammatory bowel disease (IBD) is a chronic immune-mediated condition that affects the digestive system and includes Crohn’s disease (CD) and ulcerative colitis (UC)…

Reactive Oxygen Species (ROS) are produced as a byproduct of cellular metabolism and can damage DNA, proteins, and lipids, promoting genomic instability and oncogenic signalling pathways…

Oxidative stress has been suggested to play a key role in multiple sclerosis (MS), but clinical data on oxidative stress markers in MS patients were inconsistent…